Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Human Insulin Companies

ID: MRFR/HC/0445-CR
200 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Human Insulin companies are essential contributors to diabetes management, specializing in the production and distribution of insulin products. Committed to advancing diabetes care, these organizations play a crucial role in ensuring a stable and accessible supply of human insulin, thereby improving the lives of individuals with diabetes worldwide.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Human Insulin Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)3.6%
2025 Market Size$ 19.9 Billion
2026 Market Size$ 20.6 Billion
2035 Market Size$ 28.2 Billion

Key Players

Novo Nordisk
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly and Company
Baxter International
Opportunities
  • Rising Prevalence of Diabetes
  • Increased Awareness and Education
  • Regulatory Support for Insulin Products

Top Industry Leaders in the Human Insulin Market

Human Insulin Key Companies
ย 
Latestย Human Insulinย Companies Update:

Eli Lilly and Company Received FDA approval for Mounjaro (tirzepatide), a novel dual GIP & GLP-1 receptor agonist for type 2 diabetes, offering potential benefits beyond glycemic control.

Novo Nordisk Launched their Icodec (insulin degludec) pre-filled pen in the US, offering patients a convenient and long-acting insulin option.

Sanofi Partnered with Getz Pharma to improve insulin access in developing countries through affordable pre-mixed insulin products.

Boehringer Ingelheim Collaborated with the United Nations to support diabetes prevention and care programs globally.

Biocon Biopharma Successfully launched Basalog (insulin glargine) biosimilar in India, further increasing competition and lowering insulin costs.

List ofย Human Insulinย Key companies in the market
  • Adocia
  • Merck & Co.Inc
  • Julphar
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Sanofi
  • Oramed
  • Novo Nordisk India Pvt. Ltd.
  • Eli Lilly and Company
  • Biocon
  • Tonghua Dongbao Pharmaceutical Co., Ltd.